NOBL - ETF AI Analysis
Top Page
ProShares S&P 500 Dividend Aristocrats ETF (NOBL)
Rating:71Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Solid Top Holdings
Most of the largest positions, including companies like Albemarle, Caterpillar, and Exxon Mobil, have delivered strong year-to-date results that support the fund’s overall performance.
Broad Sector Diversification
Holdings are spread across many sectors such as consumer defensive, industrials, financials, materials, and health care, which helps reduce the impact if any one area of the market struggles.
Negative Factors
Higher-Than-Index Expense Ratio
The fund’s expense ratio is meaningfully higher than many low-cost index ETFs, which slightly reduces the net return investors keep over time.
Heavy U.S. Concentration
With nearly all assets invested in U.S. companies, the ETF offers very limited international diversification and is highly tied to the U.S. market’s fortunes.
Sector Tilts May Lag in Growth Rallies
The fund’s relatively small exposure to technology and larger weight in defensive and industrial sectors could cause it to lag when high-growth areas of the market lead.
NOBL vs. SPDR S&P 500 ETF (SPY)
AUM11.04B
RegionNorth America
Expense Ratio0.35%
Beta0.53
IssuerProShares
Inception DateOct 09, 2013
Dividend Yield2.14%
Asset ClassEquity
Index TrackedS&P 500 Dividend Aristocrats
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume999,517
30 Day Avg. Volume868,327
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
121.20Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering69
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NOBL Summary
NOBL is an ETF that follows the S&P 500 Dividend Aristocrats index, which is made up of U.S. companies that have raised their dividends every year for at least 25 years. It holds well-known names like Caterpillar and Exxon Mobil, and spreads your money across many sectors such as consumer goods, industrials, and health care. Someone might invest in NOBL to seek a mix of long-term growth and steady dividend income from established, financially stable companies. A key risk is that stock prices and dividend payments can still go up and down with the overall market.
How much will it cost me?The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has an expense ratio of 0.35%, meaning you’ll pay $3.50 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed to focus on companies with a strong history of increasing dividends, which requires more research and oversight.
What would affect this ETF?The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) could benefit from stable economic conditions and a focus on dividend-paying companies, as these firms tend to perform well during periods of market uncertainty. However, rising interest rates or economic slowdowns could negatively impact sectors like Consumer Defensive and Industrials, which make up a significant portion of the ETF's holdings. Additionally, regulatory changes or challenges in the U.S. market, where the ETF is heavily focused, could pose risks to its performance.
NOBL Top 10 Holdings
NOBL’s story is less about flashy growth and more about steady, dividend-paying workhorses. Energy giants Chevron and Exxon Mobil have been the main engines lately, rising and giving the fund a helpful tailwind. Defensive names like Johnson & Johnson and NextEra Energy are contributing more quietly, with solid but not spectacular gains. On the softer side, Sysco has been lagging, acting like a small anchor on performance. Overall, the ETF is U.S.-only and leans toward defensive, income-focused sectors rather than high-flying tech.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Exxon Mobil | 1.94% | $211.65M | $680.72B | 58.70% | 74 Outperform | |
| Chevron | 1.92% | $209.46M | $396.80B | 41.89% | 71 Outperform | |
| Target | 1.71% | $186.90M | $55.34B | 29.49% | 70 Neutral | |
| Linde | 1.69% | $184.86M | $231.45B | 17.28% | 66 Neutral | |
| Air Products and Chemicals | 1.68% | $183.66M | $65.49B | 13.52% | 46 Neutral | |
| Johnson & Johnson | 1.67% | $182.40M | $580.40B | 59.98% | 78 Outperform | |
| NextEra Energy | 1.65% | $180.21M | $193.20B | 42.53% | 71 Outperform | |
| Atmos Energy | 1.65% | $179.93M | $31.07B | 29.47% | 66 Neutral | |
| Caterpillar | 1.63% | $178.16M | $335.58B | 157.53% | 76 Outperform | |
| Consolidated Edison | 1.63% | $177.80M | $41.41B | 8.74% | 62 Neutral |
NOBL Technical Analysis
Neutral
―
Price Trends
109.53
Negative
106.87
Negative
104.11
Positive
Market Momentum
-1.16
Negative
43.63
Neutral
74.04
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NOBL, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 106.12, equal to the 50-day MA of 109.53, and equal to the 200-day MA of 104.11, indicating a neutral trend. The MACD of -1.16 indicates Negative momentum. The RSI at 43.63 is Neutral, neither overbought nor oversold. The STOCH value of 74.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NOBL.
NOBL Peer Comparison
Comparison Results
Performance Comparison
NOBL
ProShares S&P 500 Dividend Aristocrats ETF
106.16
11.89
12.61%
VOO
Vanguard S&P 500 ETF
―
―
―
IVV
iShares Core S&P 500 ETF
―
―
―
SPY
SPDR S&P 500 ETF Trust
―
―
―
QQQ
Invesco QQQ Trust
―
―
―
SPYM
State Street SPDR Portfolio S&P 500 ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents